Literature DB >> 2978493

Abdominal wall defects and obstructive uropathies. Aetiology and management.

K C Pringle1.   

Abstract

Gastroschisis and omphalocele (exomphalos) are embryologically distinct, and for this reason each has its own distinct constellation of associated anomalies. The perinatal management of both gastroschisis and omphalocele addresses the controversy as to the best mode of delivery that has been expressed in the literature with regard to gastroschisis and has exercised many of those involved in antenatal diagnosis in the case of omphalocele. The post-delivery management of both of these defects is briefly discussed. Controversies surrounding the aetiology of renal dysplasia and whether urinary tract obstruction is a cause of dysplasia or an anomaly associated with dysplasia are also discussed. The options for therapy and the indications for an in utero shunting procedure are outlined as well as the controversy centred around the utility of an in utero shunt. The need for a prospective randomised trial is emphasised, together with the difficulty that is raised by the need to choose a limited number of prospective indices on which treatment decisions in such a trial must be based. The need for a long-term follow-up of all patients entered in such a trial is emphasised.

Entities:  

Mesh:

Year:  1988        PMID: 2978493     DOI: 10.1159/000263336

Source DB:  PubMed          Journal:  Fetal Ther        ISSN: 0257-2788


  2 in total

1.  Exomphalos, inguinal hernia, renal agenesis, skeletal dysplasia, heart disease--a "new" syndrome?

Authors:  G Varlamis; K Antoniades
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

2.  Obstructive azoospermia as an unusual complication associated with herniorrhaphy of an omphalocele: a case report.

Authors:  Kazunari Tsuchihashi; Kazutoshi Okubo; Kentaro Ichioka; Takeshi Soda; Koji Yoshimura; Akihiro Kanematsu; Osamu Ogawa; Hiroyuki Nishiyama
Journal:  J Med Case Rep       Date:  2011-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.